BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9701333)

  • 1. A method to differentiate between thyroglobulin derived from normal thyroid tissue and from thyroid carcinoma based on analysis of reactivity to lectins.
    Maruyama M; Kato R; Kobayashi S; Kasuga Y
    Arch Pathol Lab Med; 1998 Aug; 122(8):715-20. PubMed ID: 9701333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination of thyroglobulin from thyroid carcinoma tissue and that from benign thyroid tissues with use of competitive assay between lectin and anti-thyroglobulin antibody.
    Shimizu K; Nakamura K; Kobatake S; Satomura S; Maruyama M; Tajiri J; Kato R
    Rinsho Byori; 2007 May; 55(5):428-33. PubMed ID: 17593687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of lectin binding in benign and malignant thyroid nodules.
    Sasano H; Rojas M; Silverberg SG
    Arch Pathol Lab Med; 1989 Feb; 113(2):186-9. PubMed ID: 2916907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical demonstration of thyroglobulin in thyroid pathology.
    Stefăneanu L; Simionescu L; Aman E; Taşcă C
    Endocrinologie; 1984; 22(1):55-9. PubMed ID: 6369503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lectin histochemistry of papillary and follicular carcinoma of the thyroid gland.
    Sobrinho-Simões M; Damjanov I
    Arch Pathol Lab Med; 1986 Aug; 110(8):722-9. PubMed ID: 3089192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue binding pattern of plant lectins in benign and malignant lesions of thyroid.
    Vijayakumar T; Augustine J; Mathew L; Aleykutty MA; Nair MB; Remani P; Nair MK
    J Exp Pathol; 1992; 6(1-2):11-23. PubMed ID: 1625034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bauhinia purpurea (BPA) binding to normal and neoplastic thyroid glands.
    Sarker AB; Akagi T; Teramoto N; Nose S; Yoshino T; Kondo E
    Pathol Res Pract; 1994 Nov; 190(11):1005-11. PubMed ID: 7746733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].
    Rink T; Dembowski W; Schroth HJ; Klinger K
    Nuklearmedizin; 2000 Aug; 39(5):133-8. PubMed ID: 10984889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroglobulin and human thyroid cancer.
    Lin JD
    Clin Chim Acta; 2008 Feb; 388(1-2):15-21. PubMed ID: 18060877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroglobulin suppresses thyroid-specific gene expression in cultures of normal but not neoplastic human thyroid follicular cells.
    Ishido Y; Yamazaki K; Kammori M; Sugishita Y; Luo Y; Yamada E; Yamada T; Sellitti DF; Suzuki K
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E694-702. PubMed ID: 24433000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lectin histochemistry in rat thyroid tumours.
    Imamura Y; Sugihara H; Miyake T; Ikeda T; Noriki S; Miyoshi N; Nakanishi K; Fukuda M
    Basic Appl Histochem; 1989; 33(3):185-96. PubMed ID: 2818422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of thyroglobulin concentration in the thyroid and serum of patients with different thyroid disorders.
    Czarnywojtek A; Krysińska I; Lacka K; Stawny B; Rólski M; Jarzab B; Włoch J; Gembicki M
    Arch Immunol Ther Exp (Warsz); 2002; 50(2):143-8. PubMed ID: 12022704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histochemical demonstration of different types of poly-N-acetyllactosamine structures in human thyroid neoplasms using lectins and endo-beta-galactosidase digestion.
    Ito N; Yokota M; Kawahara S; Nagaike C; Morimura Y; Hirota T; Matsunaga T
    Histochem J; 1995 Aug; 27(8):620-9. PubMed ID: 8550383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
    Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
    J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.
    Eustatia-Rutten CF; Smit JW; Romijn JA; van der Kleij-Corssmit EP; Pereira AM; Stokkel MP; Kievit J
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):61-74. PubMed ID: 15212646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases.
    Stefăneanu L; Taşcă C
    Acta Histochem; 1986; 78(1):7-18. PubMed ID: 2421518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a new method for the diagnosis of alterations of Lens culinaris agglutinin binding of thyroglobulin molecules in thyroid carcinoma.
    Kanai T; Amakawa M; Kato R; Shimizu K; Nakamura K; Ito K; Hama Y; Fujimori M; Amano J
    Clin Chem Lab Med; 2009; 47(10):1285-90. PubMed ID: 19743952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Content of thyroglobulin polyribosomes in normal and pathological thyroid cells].
    Turakulov IaKh; Kadyrooka DA; Atakhanova BA; Leĭtinvl ; Liubimova EV
    Biokhimiia; 1979 Feb; 44(2):259-63. PubMed ID: 435565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
    Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.